bluebird bio
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has bluebird bio's balance sheet done over the years? Its assets were worth $619,161,000 last year, which is more than in the previous period. 69% of bluebird bio’s total assets is currently financed by debt. Its liabilities reached the amount of $424,624,000, which means an increase by 18% compared compared to last year.
Debt to Assets
| 2014 | 556739000 | 65.48M | 11.76% |
|---|---|---|---|
| 2015 | 1002337000 | 151.84M | 15.15% |
| 2016 | 1118122000 | 248.68M | 22.24% |
| 2017 | 1900567000 | 277.13M | 14.58% |
| 2018 | 2242844000 | 357.77M | 15.95% |
| 2019 | 1727424000 | 442.43M | 25.61% |
| 2020 | 1781252000 | 426.19M | 23.93% |
| 2021 | 593795000 | 219.51M | 36.97% |
| 2022 | 554902000 | 358.55M | 64.62% |
| 2023 | 619161000 | 424.62M | 68.58% |
0HOH.L Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 221.75M | 113.00M | 161.16M | 317.70M | 327.21M | 402.57M | 758.50M | 278.88M | 164.26M | 347.84M |
Short term investments | 0 | 67.32M | 138.34M | 833.54M | 779.24M | 982.72M | 531.60M | 425.49M | 353.68M | 125.71M |
Net receivables | 13.00M | 10.78M | 11.38M | 26.81M | 12.82M | 13.93M | 8.37M | 0 | 0 | 0 |
Inventory | 22.91M | -1.41M | -108.50M | -149.70M | -144.33M | -506.12M | -11.48M | 0 | 0 | 0 |
Other current assets | 24.00M | 8.37M | 37.01M | 64.28M | 45.71M | 19.76M | 21.17M | 19.83M | 12.03M | 12.86M |
Total current assets | 281.68M | 199.48M | 336.52M | 1.21B | 1.15B | 1.41B | 1.61B | 724.21M | 523.96M | 479.98M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 267.04M | 291.35M | 101.23M | 346.85M | 337.06M | 246.62M | 199.60M | 156.95M | 82.61M | 15.74M |
Goodwill | 5.64M | 5.64M | 5.64M | 13.12M | 13.12M | 13.12M | 13.12M | 13.12M | 13.12M | 13.12M |
Intangible assets | 10.43M | 4.86M | 0 | 10.04M | 14.32M | 13.16M | 16.93M | 20.69M | 24.45M | 28.21M |
Long term investments | 0 | 1.41M | 97.11M | 122.89M | 131.50M | 506.12M | 324.19M | 180.45M | 347.81M | 18.44M |
Other non-current assets | 54.34M | 52.12M | 53.27M | 72.80M | 79.22M | 44.80M | 23.94M | 22.67M | 10.36M | -698K |
Total non-current assets | 337.47M | 355.41M | 257.27M | 565.71M | 575.25M | 823.84M | 286.26M | 393.90M | 478.37M | 76.75M |
Total assets | 619.16M | 554.90M | 593.79M | 1.78B | 1.72B | 2.24B | 1.90B | 1.11B | 1.00B | 556.73M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 1.50M | 2.28M | 11.55M | 18.85M | 29.20M | 25.67M | 6.20M | 5.88M | 25.37M |
Short term debt | 105.90M | 51.16M | 23.15M | 25.02M | 20.17M | 1.42M | 1.05M | 50.18M | 0 | 0 |
Total current liabilities | 200.11M | 128.23M | 152.99M | 203.58M | 223.58M | 146.43M | 95.61M | 74.53M | 40.36M | 42.97M |
| Non-current liabilities: | ||||||||||
Long term debt | 224.41M | 230.23M | 66.43M | 167.99M | 170.81M | 153.31M | 154.74M | 120.14M | 61.90M | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 92K | 92K | 93K | 7.26M | 10.41M | 8.33M | 5.01M | 3.39M | 13.61M | 15.28M |
Total non-current liabilities | 224.51M | 230.32M | 66.52M | 222.60M | 218.85M | 211.34M | 181.52M | 174.14M | 111.47M | 22.50M |
Total liabilities | 424.62M | 358.55M | 219.51M | 426.19M | 442.43M | 357.77M | 277.13M | 248.68M | 151.84M | 65.48M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |